Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (M
- This topic has 0 replies, 1 voice, and was last updated 2 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
https://www.sciencedirect.com/science/article/pii/S1470204521003363?dgcid=author
Thanks to Elsevier Ltd for this piece.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.